We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPHE icon
276
iShares MSCI Philippines ETF
EPHE
$127M
$1.02M 0.02%
26,915
+5,731
+27% +$218K
MHNB.CL
277
DELISTED
Maiden Holdings North America
MHNB.CL
$1.02M 0.02%
38,800
+1,515
+4% +$39.6K
BAP icon
278
Credicorp
BAP
$30.9B
$1.02M 0.02%
6,638
+1,322
+25% +$203K
HOLX
279
DELISTED
Hologic
HOLX
$1.01M 0.02%
41,330
-2,975
-7% -$75.1K
SQM icon
280
Sociedad Química y Minera de Chile
SQM
$19.6B
$1M 0.02%
39,370
+7,954
+25% +$217K
TSM icon
281
TSMC
TSM
$2.09T
$999K 0.02%
49,482
-7,190
-13% -$150K
WY icon
282
Weyerhaeuser
WY
$17.3B
$988K 0.02%
31,008
+6,594
+27% +$216K
JCI icon
283
Johnson Controls International
JCI
$87.5B
$981K 0.02%
21,286
+2,114
+11% +$107K
DCP
284
DELISTED
DCP Midstream, LP
DCP
$975K 0.02%
17,915
VEDL
285
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$974K 0.02%
56,422
+15,696
+39% +$296K
LMT icon
286
Lockheed Martin
LMT
$134B
$969K 0.02%
5,299
+46
+0.9% +$7.83K
BAC icon
287
Bank of America
BAC
$435B
$962K 0.02%
56,431
-7,079
-11% -$113K
INGR icon
288
Ingredion
INGR
$6.38B
$961K 0.02%
12,685
+2,890
+30% +$225K
NKE icon
289
Nike
NKE
$61.9B
$945K 0.02%
21,198
-572
-3% -$22.7K
BP icon
290
BP
BP
$113B
$939K 0.02%
26,111
XLE icon
291
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$939K 0.02%
20,722
-488
-2% -$23.6K
FNV icon
292
Franco-Nevada
FNV
$41.4B
$923K 0.02%
18,875
+3,650
+24% +$203K
FULLL
293
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
$922K 0.02%
34,800
+3,000
+9% +$78.8K
BHP icon
294
BHP
BHP
$213B
$912K 0.02%
18,317
+3,026
+20% +$176K
AMGN icon
295
Amgen
AMGN
$203B
$911K 0.02%
6,483
-134,593
-95% -$17.6M
TEVA icon
296
Teva Pharmaceuticals
TEVA
$35.9B
$911K 0.02%
16,950
+13
+0.1% +$689
NFLX icon
297
Netflix
NFLX
$292B
$904K 0.02%
140,210
-85,190
-38% -$553K
FMX icon
298
Fomento Económico Mexicano
FMX
$43.3B
$903K 0.02%
9,815
+1,850
+23% +$176K
IWD icon
299
iShares Russell 1000 Value ETF
IWD
$82B
$901K 0.02%
9,004
+871
+11% +$88.2K
IWB icon
300
iShares Russell 1000 ETF
IWB
$47.7B
$898K 0.02%
8,171
+9
+0.1% +$995

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.